Additionally, much of the literature has focused on the long-term effects of FGF1 using diabetic rodent models with disrupted leptin signaling, and much less is known about the mechanisms underlying acute effects of FGF1, which are independent of long-term reductions in hyperglycemia (5, 8, 20). The gene discussed is FGF1; the disease is Hyperglycemia.